Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 9;11(5):850.
doi: 10.3390/diagnostics11050850.

Value of Hematological and Coagulation Parameters as Prognostic Factors in Acute Coronary Syndromes

Elena Emilia Babes  1   2 , Dana Carmen Zaha  2   3 , Delia Mirela Tit  4   5 , Aurelia Cristina Nechifor  6 , Simona Bungau  4   5 , Felicia Liana Andronie-Cioara  7 , Tapan Behl  8 , Manuela Stoicescu  1   2 , Mihai Alexandru Munteanu  1   2 , Marius Rus  1   2 , Mirela Marioara Toma  4   5 , Ciprian Brisc  1   2
Affiliations

Value of Hematological and Coagulation Parameters as Prognostic Factors in Acute Coronary Syndromes

Elena Emilia Babes et al. Diagnostics (Basel). .

Abstract

The values of hematological and coagulation biomarkers were evaluated as predictors of in hospital mortality and complications, in patients with acute coronary syndromes (ACS). This retrospective observational study enrolled 936 ACS subjects admitted to the Clinical Emergency Hospital of Oradea, Romania, between January-December 2019. Hematological and coagulation parameters were obtained at admission. During hospitalization, the following adverse events were recorded: death, ventricular rhythm disturbances, atrial fibrillation, heart failure, re-infarction, and stroke. Accuracy of hematological and coagulation parameters as predictors of adverse outcome were also evaluated. The diagnosis was unstable angina in 442 patients (47.22%), non-ST-elevation myocardial infarction (NSTEMI) in 113 patients (12.1%) and ST-elevation myocardial infarction (STEMI) in 381 patients (40.70%); 87 patients (9.29%) died during hospitalization and 193 (20.7%) developed complications. Predictors for in hospital mortality were as follows: red cell distribution width (RDW) (AUC 0.691, p < 0.0001), white blood cells (WBC) (AUC 0.684, p < 0.0001), neutrophils (NEU) (AUC 0.684, p < 0.0001), and prothrombin time (PT) (AUC 0.765, p < 0.0001). WBC (AUC 0.659, p < 0.0001), NEU (AUC 0.664, p < 0.0001), RDW (AUC 0.669, p < 0.0001), and PT (AUC 0.669, 95% CI 0.622-0.714, p < 0.0001) also had accuracy for complications prediction. RDW had a good ability to predict heart failure in NSTEMI patients (AUC 0.832, p < 0.0001). An acceptable ability to predict ventricular rhythm disturbances occurrence had WBC (AUC 0.758, p < 0.0001) and NEU (AUC 0.772, p < 0.0001). Hematological and coagulation parameters can help in risk stratification of ACS patients. RDW, WBC, NEU, and PT were able to predict mortality and in-hospital complications in ACS patients. RDW has a good accuracy in predicting complications and heart failure in NSTEMI patients. WBC and NEU are good predictors for ventricular rhythm disturbances.

Keywords: acute coronary syndromes; adverse events; coagulation parameters; hematological parameters; prognostic factors.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow chart presenting the inclusion-exclusion criteria of the patients.
Figure 2
Figure 2
ROC curves for mortality prediction in ACS. Legend: PT—prothrombin time; NEU—neutrophils; RDW—red cell distribution width; WBC—white blood cells; HGB—hemoglobin; ACS —acute coronary syndrome.
Figure 3
Figure 3
ROC curves for complications prediction in ACS. Legend: RDW—red cell distribution width; PT—prothrombin time; NEU—neutrophils; WBC—white blood cells; HGB—hemoglobin; ACS—acute coronary syndrome.
See this image and copyright information in PMC

References

    1. Yeh R.W., Sidney S., Chandra M., Sorel M., Selby J.V., Go A.S. Population trends in the incidence and outcomes of acute myocardial infarction. N. Engl. J. Med. 2010;362:2155–2165. doi: 10.1056/NEJMoa0908610. - DOI - PubMed
    1. Ibanez B., James S., Agewall S., Antunes M.J., Bucciarelli-Ducci C., Bueno H., Caforio A.L.P., Crea F., Goudevenos J.A., Halvorsen S., et al. ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) Eur. Heart J. 2018;39:119–177. - PubMed
    1. Virani S.S., Alonso A., Benjamin E.J., Bittencourt M.S., Callaway C.W., Carson A.P., Chamberlain A.M., Chang A.R., Cheng S., Delling F.N., et al. Heart Disease and Stroke Statistics-2020 update: A report from the American Heart Association. Circulation. 2020;141:e139–e596. doi: 10.1161/CIR.0000000000000757. - DOI - PubMed
    1. Budzianowski J., Pieszko K., Burchardt P., Rzeźniczak J., Hiczkiewicz J. The Role of Hematological Indices in Patients with Acute Coronary Syndrome. Dis. Markers. 2017;2017:3041565. doi: 10.1155/2017/3041565. - DOI - PMC - PubMed
    1. Sabatine M.S., Morrow D.A., Cannon C.P., Murphy S.A., Demopoulos L.A., DiBattiste P.M., McCabe C.H., Braunwald E., Gibson C.M. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes. J. Am. Coll. Cardiol. 2002;40:1761–1768. doi: 10.1016/S0735-1097(02)02484-1. - DOI - PubMed